by ARSACS | May 8, 2019 | News Archives
If you are interested in doing research on ARSACS, please send us your proposal by Friday May 24,2019. A maximum of $100,000 for a period of one year with possibility of renewal for a second yearApplication and Appendix
by ARSACS | Apr 29, 2019 | News Archives
On April 25th in Quebec City, Sonia Gobeil had the pleasure of meeting Dr. Esther Becker (Oxford University) and attending her conference on the cerebellum entitled “New Insights into Cerebellar Disorders”. Summary.
by ARSACS | Apr 24, 2019 | News Archives, Past Conferences
Dr. Cynthia Gagnon will be presenting on the Natural History, Biomarkers and Endpoints for ARSACS at the November 2019 International Ataxia Research Conference in Washington, DC
by ARSACS | Apr 18, 2019 | News Archives
“Speech treatment improves dysarthria in multisystemic ataxia: a raterblinded, controlled pilot-study in ARSACS” research study done by Dr. Synofzik and his research team to be published in the Journal of Neurology. To learn more about the study, interested readers...
by ARSACS | Apr 14, 2019 | News Archives
Article will be published in the Journal of the Neurological Sciences in May, 2019. The study concludes that adults with ARSACS may experience many other clinical manifestations than the most commonly described. See Article.
by ARSACS | Apr 11, 2019 | News Archives
EMG data of 6 muscles from 35 ARSACS patients were obtained as part of Dr. Luc J. Hébert’s ARSACS research project. The analysis of these EMG data will help to better understand the problem of spasticity in ARSACS patients and could eventually open the door to...
by ARSACS | Apr 7, 2019 | News Archives
The University of North Carolina (UNC) Catalyst for Rare Diseases, funded in 2016, was established as a precompetitive open research group with a mission to understand the functional phenotic manifestations of genetic mutations. This article describes the initial...
by ARSACS | Apr 3, 2019 | News Archives
Invitation to join us at the 13th edition of the Diner des Producteurs, major annual fundraising event for the Ataxia Charlevoix-Saguenay Foundation. Discover the fine cuisine prepared by guest chef Pierre Gagnaire 3 Michelin stars, wines from La Maison E. Guigal. You...
by ARSACS | Mar 28, 2019 | News Archives, Past Conferences
Opportunity to meet Dr. Esther Becker from University of Oxford guest speaker at the NeuroForum 2019 conference and find out the «New insights into cerebellar disorders». The conference, organised by the Axe NeuroSciences, Centre de Recherche du CHU de Québec, will be...
by ARSACS | Mar 22, 2019 | News Archives
Dr. Alanna Watt talks about her lab’s research in understanding the cerebellum and the cellular changes that contribute to ARSACS in order to develop therapeutics. Presentation.
by ARSACS | Mar 19, 2019 | News Archives
The research of Dr. Roxanne Larivière and her team supports that Sacs missense mutation largely leads to loss of Sacsin fucntion. SacsR272C missense homozygous mice develop an ataxia phenotype published in the Molecular Brain.
by ARSACS | Mar 8, 2019 | News Archives
The next meeting of the Board of the Ataxia Charlevoix-Saguenay Foundation will be held in Montreal on Wednesday June 5,2019.
by ARSACS | Mar 7, 2019 | News Archives
Dr. Chapple from Queen Mary University of London provides an overview of his ARSACS research.
by ARSACS | Mar 4, 2019 | News Archives
In addition to evaluating a post-symptomatic treatment on Sacs mice with an identified drug, Dr. Maltecca is also conducting a pre-symptomatic treatment to evaluate if such a drug can stop the neurodegeneration associated with ARSACS. Such results will be available at...
by ARSACS | Feb 27, 2019 | News Archives
Dr. Anne McKinney from McGill University describes her ARSACS research project focusing on how the cells of ARSACS patients communicate together and how some drugs could have an impact on the cells.
by ARSACS | Feb 25, 2019 | News Archives
Dr. Slaven Erceg’s article “Investigating ARSACS: models for understanding cerebellar degeneration” has been published in the Neuropathology and Applied Neurobiology journal last January. Dr. Erceg is at the Stem Cells Therapies in Neurodegenerative...
by ARSACS | Feb 23, 2019 | News Archives
Dre Cynthia Gagnon presents some preventive interventions and pratical tips that could be helpful if you are affected by ARSACS. This is a general overview and you should discuss with your neurologist or medical team to ensure that some of the recommendations are...
by ARSACS | Feb 17, 2019 | News Archives
As part of the video serie of ARSACS research projects, Dr. Suran Nethsisinghe from UCL Queen Square Institute of Neurology in London provides a short overview of his research project using skin cells.
by ARSACS | Feb 15, 2019 | News Archives
You are invited to a conference on ARSACS research done in the Saguenay/Lac St-Jean region. The conference will take place on February 28, coincident with the International Rare Disease Day, at the salle polyvalente of the library in Jonquière, Quebec. Dr. Cynthia...
by ARSACS | Feb 11, 2019 | News Archives
This is a special invitation to submit your research proposal. Each year, the Foundation offers annual research fellowships that will advance the understanding of the disease and lead to a treatment. A maximum of $100,000 for a period of one year with possibility of...
